Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A S Muldowney

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Autonomic Neuroscience : Basic & Clinical|June 20, 2020
Management of neurogenic orthostatic hypotension in the heart failure patientDebra D Dixon, James A S Muldowney
Expert Opinion on Drug Metabolism & Toxicology|September 25, 2012
The pharmacokinetics and pharmacodynamics of valsartan in the post-myocardial infarction populationCassandra D Benge, James A S Muldowney
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2002
Microarray analysis of neointima: flowing toward a clear futureShawn E Levy, James A S Muldowney
Lancet (London, England)|January 30, 2010
Combination therapy with clopidogrel and proton-pump inhibitorsJames A S Muldowney, Cassandra D Benge
Journal of Pharmacy Practice|June 1, 2021
Evaluation of a Clinical Pharmacist Specialist Transition of Care Pathway to Manage Heart Failure Readmissions During a Provider ShortageCassandra Benge, Jonathon Pouliot, James A S Muldowney
Hypertension (Dallas, Tex. : 1979)|January 25, 2006
Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibitionNancy J Brown, James A S Muldowney, Douglas E Vaughan
Tennessee Medicine : Journal of the Tennessee Medical Association|May 22, 2009
A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapyChad V Pecot, Michael Fuller, James A S Muldowney, et al.
Angiology|February 21, 2012
Pentoxifylline lowers plasminogen activator inhibitor 1 levels in obese individuals: a pilot studyJames A S Muldowney, Qingxia Chen, Dana L Blakemore, et al.
Hypertension (Dallas, Tex. : 1979)|September 24, 2004
NO synthase inhibition increases aldosterone in humansJames A S Muldowney, Stephen N Davis, Douglas E Vaughan, et al.
The American Journal of Medicine|August 20, 2021
Management of Orthostatic Hypotension in the Hospitalized Patient: A Narrative ReviewAmr Wahba, Cyndya A Shibao, James A S Muldowney, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Autonomic Neuroscience : Basic & Clinical|June 20, 2020
Management of neurogenic orthostatic hypotension in the heart failure patientDebra D Dixon, James A S Muldowney
Expert Opinion on Drug Metabolism & Toxicology|September 25, 2012
The pharmacokinetics and pharmacodynamics of valsartan in the post-myocardial infarction populationCassandra D Benge, James A S Muldowney
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2002
Microarray analysis of neointima: flowing toward a clear futureShawn E Levy, James A S Muldowney
Lancet (London, England)|January 30, 2010
Combination therapy with clopidogrel and proton-pump inhibitorsJames A S Muldowney, Cassandra D Benge
Journal of Pharmacy Practice|June 1, 2021
Evaluation of a Clinical Pharmacist Specialist Transition of Care Pathway to Manage Heart Failure Readmissions During a Provider ShortageCassandra Benge, Jonathon Pouliot, James A S Muldowney
Hypertension (Dallas, Tex. : 1979)|January 25, 2006
Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibitionNancy J Brown, James A S Muldowney, Douglas E Vaughan
Tennessee Medicine : Journal of the Tennessee Medical Association|May 22, 2009
A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapyChad V Pecot, Michael Fuller, James A S Muldowney, et al.
Angiology|February 21, 2012
Pentoxifylline lowers plasminogen activator inhibitor 1 levels in obese individuals: a pilot studyJames A S Muldowney, Qingxia Chen, Dana L Blakemore, et al.
Hypertension (Dallas, Tex. : 1979)|September 24, 2004
NO synthase inhibition increases aldosterone in humansJames A S Muldowney, Stephen N Davis, Douglas E Vaughan, et al.
The American Journal of Medicine|August 20, 2021
Management of Orthostatic Hypotension in the Hospitalized Patient: A Narrative ReviewAmr Wahba, Cyndya A Shibao, James A S Muldowney, et al.
Pageof 3